179 related articles for article (PubMed ID: 23936393)
1. Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma.
Ellsworth KA; Eckloff BW; Li L; Moon I; Fridley BL; Jenkins GD; Carlson E; Brisbin A; Abo R; Bamlet W; Petersen G; Wieben ED; Wang L
PLoS One; 2013; 8(8):e70216. PubMed ID: 23936393
[TBL] [Abstract][Full Text] [Related]
2. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.
Ellsworth KA; Moon I; Eckloff BW; Fridley BL; Jenkins GD; Batzler A; Biernacka JM; Abo R; Brisbin A; Ji Y; Hebbring S; Wieben ED; Mrazek DA; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2013 Mar; 23(3):156-66. PubMed ID: 23324805
[TBL] [Abstract][Full Text] [Related]
3. FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer.
Hou J; Wang L
PLoS One; 2012; 7(5):e36252. PubMed ID: 22590527
[TBL] [Abstract][Full Text] [Related]
4. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.
Schirmer MA; Lüske CM; Roppel S; Schaudinn A; Zimmer C; Pflüger R; Haubrock M; Rapp J; Güngör C; Bockhorn M; Hackert T; Hank T; Strobel O; Werner J; Izbicki JR; Johnsen SA; Gaedcke J; Brockmöller J; Ghadimi BM
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26857392
[TBL] [Abstract][Full Text] [Related]
5. The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoid-regulated genes, dependent on trauma exposure.
Yeo S; Enoch MA; Gorodetsky E; Akhtar L; Schuebel K; Roy A; Goldman D
Genes Brain Behav; 2017 Feb; 16(2):223-232. PubMed ID: 27648526
[TBL] [Abstract][Full Text] [Related]
6. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
Innocenti F; Owzar K; Jiang C; Etheridge AS; Gordân R; Sibley AB; Mulkey F; Niedzwiecki D; Glubb D; Neel N; Talamonti MS; Bentrem DJ; Seiser E; Yeh JJ; Van Loon K; McLeod H; Ratain MJ; Kindler HL; Venook AP; Nakamura Y; Kubo M; Petersen GM; Bamlet WR; McWilliams RR
PLoS One; 2018; 13(8):e0202272. PubMed ID: 30107003
[TBL] [Abstract][Full Text] [Related]
7. Relationship between single nucleotide polymorphisms in the deoxycytidine kinase gene and chemosensitivity of gemcitabine in six pancreatic cancer cell lines.
Si S; Liao Q; Zhao YP; Hu Y; Zhang Q; You LL
Chin Med J (Engl); 2011 Feb; 124(3):419-22. PubMed ID: 21362344
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer.
Li L; Zhang JW; Jenkins G; Xie F; Carlson EE; Fridley BL; Bamlet WR; Petersen GM; McWilliams RR; Wang L
Pharmacogenet Genomics; 2016 Dec; 26(12):527-537. PubMed ID: 27749787
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.
Kirby MK; Ramaker RC; Gertz J; Davis NS; Johnston BE; Oliver PG; Sexton KC; Greeno EW; Christein JD; Heslin MJ; Posey JA; Grizzle WE; Vickers SM; Buchsbaum DJ; Cooper SJ; Myers RM
Mol Oncol; 2016 Oct; 10(8):1169-82. PubMed ID: 27282075
[TBL] [Abstract][Full Text] [Related]
10. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.
Harris M; Bhuvaneshwar K; Natarajan T; Sheahan L; Wang D; Tadesse MG; Shoulson I; Filice R; Steadman K; Pishvaian MJ; Madhavan S; Deeken J
Pharmacogenet Genomics; 2014 Feb; 24(2):81-93. PubMed ID: 24401833
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms.
Maltese P; Palma L; Sfara C; de Rocco P; Latiano A; Palmieri O; Corritore G; Annese V; Magnani M
Pharmacogenomics J; 2012 Oct; 12(5):432-8. PubMed ID: 21788965
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.
Lin Y; Ge X; Wen Y; Shi ZM; Chen QD; Wang M; Liu LZ; Jiang BH; Lu Y
Oncotarget; 2016 Oct; 7(43):70857-70868. PubMed ID: 27765914
[TBL] [Abstract][Full Text] [Related]
14. Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency.
Sabbagh JJ; O'Leary JC; Blair LJ; Klengel T; Nordhues BA; Fontaine SN; Binder EB; Dickey CA
PLoS One; 2014; 9(9):e107241. PubMed ID: 25191701
[TBL] [Abstract][Full Text] [Related]
15. The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.
Spratlin J; Sangha R; Glubrecht D; Dabbagh L; Young JD; Dumontet C; Cass C; Lai R; Mackey JR
Clin Cancer Res; 2004 Oct; 10(20):6956-61. PubMed ID: 15501974
[TBL] [Abstract][Full Text] [Related]
16. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
[TBL] [Abstract][Full Text] [Related]
17. The association of FKBP5 polymorphism with asthma susceptibility in asthmatic patients.
Alsaffar SF; Alqaraghuli HA; Yenzeel JH; Ghazi HF
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):479-484. PubMed ID: 34214377
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Innocenti F; Owzar K; Cox NL; Evans P; Kubo M; Zembutsu H; Jiang C; Hollis D; Mushiroda T; Li L; Friedman P; Wang L; Glubb D; Hurwitz H; Giacomini KM; McLeod HL; Goldberg RM; Schilsky RL; Kindler HL; Nakamura Y; Ratain MJ
Clin Cancer Res; 2012 Jan; 18(2):577-84. PubMed ID: 22142827
[TBL] [Abstract][Full Text] [Related]
19. FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus.
Gan YL; Wang CY; He RH; Hsu PC; Yeh HH; Hsieh TH; Lin HC; Cheng MY; Jeng CJ; Huang MC; Lee YH
J Neuroinflammation; 2022 Jun; 19(1):152. PubMed ID: 35705957
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.
Menke A; Klengel T; Rubel J; Brückl T; Pfister H; Lucae S; Uhr M; Holsboer F; Binder EB
Genes Brain Behav; 2013 Apr; 12(3):289-96. PubMed ID: 23406438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
